Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07447869) titled 'LYmph Node eXamination in Cat Allergen Immunotherapy' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Condition: Allergy

Intervention: Drug: Intradermal cat allergen challenge

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: March 19, 2026

Target Sample Size: 16

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07447...